What's breaking now, across thousands of outlets.
Aviceda Therapeutics, a biotech that had planned to take an eye drug into Phase 3 this year despite a mid-stage clinical setback, is in the process of winding down, a source familiar with the decision ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
(MedPage Today) -- You passed medical training, now see if you can pass our weekly quiz
The Society’s Pinktober 2026 message, themed “Early Action, Better Outcomes,” says breast cancer remains a major health challenge in Ghana and is the leading cause of cancer and cancer deaths among…
Researchers at Semmelweis University examined the connection between childhood trauma and adult suicide risk among 300 psychiatric inpatients.
FDA Chief Scientist Steven Kozlowski, MD, said the updated FARS would come out early in FY 2027 but offered no further specifics on timing.
Sen. Chuck Grassley (R-Iowa) on Friday called on the Trump administration to finalize its proposed rule limiting the sale of kratom, a plant with opioid-like properties that can be bought over the…
(MedPage Today) -- Investigational gefurulimab, a dual-binding nanobody that blocks complement component 5 (C5) activation, sustained functional improvements for 1 year in people with generalized…
